Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1998
09/17/1998WO1998040344A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
09/17/1998WO1998040105A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
09/17/1998WO1998040103A1 Process for increasing the therapeutic effect and reducing the toxicity of drugs, metals, and organic and inorganic compounds
09/17/1998WO1998040102A1 Cytoprotective agents comprising monoamine oxidase inhibitors
09/17/1998WO1998040092A1 Dolastatin-15 derivatives in combination with taxanes
09/17/1998WO1998040090A1 Methods for inhibiting bacterial cytotoxicity
09/17/1998WO1998040085A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate
09/17/1998WO1998040082A1 THE USE OF WATER-SOLUBLE β-GLUCANS AS ACTIVE SUBSTANCES IN THE PRODUCTION OF THERAPEUTIC AGENTS IN SKIN TREATMENT
09/17/1998WO1998040081A1 Sulfated oligosaccharides having anticoagulant/antithrombotic activity
09/17/1998WO1998040080A1 Oxyalkylene phosphate compounds and uses thereof
09/17/1998WO1998040079A1 Serine proteinase inhibitory activity by hydrophobic tetracycline
09/17/1998WO1998040077A1 Anti-angiogenic agents
09/17/1998WO1998040076A1 Compositions for the treatment of climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with partial estrogen antagonists
09/17/1998WO1998040075A1 Composition for the treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors
09/17/1998WO1998040074A1 Cosmetic or dermatological use of 7-hydroxylated steroids
09/17/1998WO1998040073A1 Drugs for relieving diabetic vascular lesion
09/17/1998WO1998040072A1 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
09/17/1998WO1998040071A1 Identification of agents for use in the treatment of alzheimer's disease
09/17/1998WO1998040070A1 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
09/17/1998WO1998040069A2 Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
09/17/1998WO1998040068A1 Heterocyclic agents
09/17/1998WO1998040067A1 Use of benzofuran derivatives for reducing death rate after myocardial infarction
09/17/1998WO1998040065A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
09/17/1998WO1998040064A1 Butyrate prodrugs derived from lactic acid
09/17/1998WO1998040063A1 Quaternary salts of 2-hydroxy acids
09/17/1998WO1998040062A1 Use of liposomes containing a chelating agent, a fungicide or a secropine for improving mucosal vaccination
09/17/1998WO1998040061A1 Use of r-nsaid's for the prevention of alzheimer's disease
09/17/1998WO1998040060A1 Solid, non-deliquescent formulations of sodium valproate
09/17/1998WO1998040059A1 Unsaturated fatty acid anhydrides for use in therapy
09/17/1998WO1998040058A2 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
09/17/1998WO1998040057A1 Spermicide
09/17/1998WO1998040056A2 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties
09/17/1998WO1998040055A2 Anti-epileptogenic agents
09/17/1998WO1998040054A1 An enteric coated oral dosage form comprising sodium amoxycillin
09/17/1998WO1998040053A1 Dosage forms comprising separate portions of r- and s-enantiomers
09/17/1998WO1998040052A1 Cationic lipid compositions targeting angiogenic endothelial cells
09/17/1998WO1998040050A1 Calcium composition
09/17/1998WO1998040047A1 Agents for promoting oral hygiene and oral health
09/17/1998WO1998039970A1 Quinoline leukotriene antagonists
09/17/1998WO1998039967A1 A method for treating or preventing alzheimer's disease
09/17/1998WO1998032467A3 Method and conjugate for treating h. pylori infection
09/17/1998WO1998031354A3 Use of 5-HT2b agonists or potentiators in CNS disorders
09/17/1998WO1998031343A3 Aqueous suspension for nasal administration of loteprednol
09/17/1998WO1998030242A3 Photochemotherapeutic compositions
09/17/1998WO1998028282A3 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
09/17/1998WO1998025594A3 Lamotrigine in the treatment and prophylaxis of migraine
09/17/1998WO1998023244A3 Intracoronary stents containing quinazolinone derivatives
09/17/1998WO1998007850A3 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
09/17/1998DE3348493C2 Di:hydro-poly:prenyl alcohol and ester and ether derivs.
09/17/1998DE19805370A1 New aromatic amino compounds
09/17/1998DE19711053A1 Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol Combination preparation of 2-methyl-thiazolidine-2,4-dicarboxylic acid and acetaminophen
09/17/1998DE19711052A1 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agent
09/17/1998DE19710916A1 Ascorbinsäure als Adjuvans bei der Beseitigung von Gefäßverschlüssen Ascorbic acid as an adjuvant in removing vascular occlusions
09/17/1998DE19710907A1 Ascorbinsäure als Adjuvans in der Chemo- und Strahlentherapie von Malignomen Ascorbic acid as an adjuvant in chemotherapy and radiotherapy of malignancies
09/17/1998DE19710368A1 Verwendung von wasserlöslichen beta-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung Use of water soluble beta-glucans as active ingredients for the preparation of therapeutic agents for skin treatment
09/17/1998DE19710068A1 Mittel zur Förderung der Mundhygiene und der Mundgesundheit Means of promoting oral hygiene and oral health
09/17/1998DE19710054A1 Pharmazeutische Zubereitung Pharmaceutical composition
09/17/1998DE19709877A1 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate 1,5-dihydro-pyrazolo [3,4-d] -pyrimidinone derivatives
09/17/1998DE19706490C1 Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen Process for the preparation of acid amides and the metalation of compounds and use of the compounds prepared by the processes
09/17/1998DE19706489A1 Verwendung von 2-Desoxyglucose zur Suppression viraler Transkription Using 2-deoxyglucose for suppression of viral transcription
09/17/1998CA2521212A1 Anti-epileptogenic agents
09/17/1998CA2323889A1 A method for treating or preventing alzheimer's disease
09/17/1998CA2285446A1 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties
09/17/1998CA2284183A1 Stable solid preparation containing vitamin d3 and tricalcium phosphate
09/17/1998CA2284163A1 Hiv protease inhibitors
09/17/1998CA2284001A1 Cytoprotective agents comprising monoamine oxidase inhibitors
09/17/1998CA2283990A1 Sulfated oligosaccharides having anticoagulant/antithrombotic activity
09/17/1998CA2283863A1 Use of liposomes containing a chelating agent, a fungicide or a secropine for improving mucosal vaccination
09/17/1998CA2283626A1 Modified protein kinase a-specific oligonucleotides and methods of their use
09/17/1998CA2283575A1 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and hmg co-a reductase inhibitors
09/17/1998CA2283490A1 Fiv vaccine
09/17/1998CA2283485A1 Spermicide
09/17/1998CA2283313A1 Anti-epileptogenic agents
09/17/1998CA2283211A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives
09/17/1998CA2283184A1 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives
09/17/1998CA2283182A1 Ring opening metathesis of alkenes
09/17/1998CA2283173A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
09/17/1998CA2283162A1 Oxyalkylene phosphate compounds and uses thereof
09/17/1998CA2283127A1 Heterocyclic agents
09/17/1998CA2283108A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
09/17/1998CA2282710A1 Lta4 hydrolase inhibitors
09/17/1998CA2282398A1 Inhibitors of impdh enzyme
09/17/1998CA2282349A1 Lta4 hydrolase inhibitors
09/17/1998CA2254925A1 Drugs for relieving diabetic vascular lesion
09/17/1998CA2254078A1 Solid, non-deliquescent formulations of sodium valproate
09/17/1998CA2253588A1 Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
09/16/1998EP0864653A1 Process for production of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha, alpha-dimethylphenyl acetic acid and phosphorylated derivatives
09/16/1998EP0864648A1 Method for screening compounds regulating the expression of human-inducible nitric oxide synthase
09/16/1998EP0864583A2 Alkali metal 8,9-dehydroestrone sulfate esters
09/16/1998EP0864582A2 Hypolipidemic 1,4-benzothiazepine-1,-dioxides
09/16/1998EP0864581A1 Secomacrolides and process for their preparation
09/16/1998EP0864579A2 Bismuth salts of moenomycin-like antibiotics, preparation, use and pharmaceuticals containing such salts
09/16/1998EP0864578A2 Platinum (IV) complex and pharmaceutical composition comprising the same
09/16/1998EP0864568A1 Agents for treatment of cardiac diseases
09/16/1998EP0864563A1 N-Acyl-hydroxy amino acid esters used to protect skin and hair
09/16/1998EP0864561A1 Benzenesulfonylamine derivatives,process for their preparation and pharmaceutical compositions containing them
09/16/1998EP0864559A1 Substituted amino compounds and their use as analgesic active substances
09/16/1998EP0864327A1 Use of pyrimidin derivatives to prevent cancer
09/16/1998EP0864325A2 Solid, at least two phase pharmaceutical preparation comprising an opioid analgesic with delayed release
09/16/1998EP0864087A1 Combinatorial dihydrobenzopyran library
1 ... 6606 6607 6608 6609 6610 6611 6612 6613 6614 6615 6616 6617 6618 6619 6620 6621 6622 6623 6624 6625 6626 ... 7860